Targeted Oncology: Highlighting current advances for the treatment of myeloproliferative neoplasms

Ruben Mesa, M.D., director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, discusses the current state of the treatment landscape for patients with myeloproliferative neoplasms (MPNs).

Read the full story at Targeted Oncology